Valeant Pharmaceuticals International (VRX) : Money flow in the Valeant Pharmaceuticals International (VRX) stock was negative (7.94 million) on Tuesday, which shows that the investors used the strength in the stock price to reduce their holdings. The total traded value on upticks was $98.88 million, compared to $106.83 million on downticks. The total uptick to downtick ratio was 0.93, indicating the underlying weakness in the stock. Even in block trades, money flow was negative ($1.8 million), indicating selling on the strength. The transaction value during uptick in block trades was $12.71 million. Downtick transaction value in block trades amounted to $10.91 million, indicating persistent selling. The uptick to downtick ratio was 1.16. Valeant Pharmaceuticals International (VRX) traded $0.13 higher at $23.22 gaining 0.56% over the previous days close.
The company Insiders own 8.62% of Valeant Pharmaceuticals International shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 9.12% . Institutional Investors own 78.41% of Valeant Pharmaceuticals International shares. During last six month period, the net percent change held by insiders has seen a change of 9.12%. In an insider trading activity, Ross Thomas W. Sr., Director of Valeant Pharmaceuticals International, Inc., had purchased 4,000 shares on June 13, 2016. The total value of the transaction was $97,600. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Shares of Valeant Pharmaceuticals International, Inc. appreciated by 16.39% during the last five trading days but lost 3.81% on a 4-week basis. Valeant Pharmaceuticals International, Inc. has dropped 27.41% during the last 3-month period . Year-to-Date the stock performance stands at -77.16%.
Valeant Pharmaceuticals International (NYSE:VRX): stock turned positive on Tuesday. Though the stock opened at $23.21, the bulls momentum made the stock top out at $23.9 level for the day. The stock recorded a low of $23.13 and closed the trading day at $23.22, in the green by 0.56%. The total traded volume for the day was 19,457,031. The stock had closed at $23.09 in the previous days trading.
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over 100 countries. The Company operates through two segments: developed markets and emerging markets. The Companys developed markets segment consists of sales in the United States of pharmaceutical products, OTC products, and medical device products. The Companys Emerging Markets segment consists of branded generic pharmaceutical products and branded pharmaceuticals, OTC products, and medical device products.